» Articles » PMID: 12705635

Cell Membrane Glycosylation Mediates the Adhesion, Migration, and Invasion of Ovarian Carcinoma Cells

Overview
Specialty Oncology
Date 2003 Apr 23
PMID 12705635
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that ovarian carcinoma cell adhesion to mesothelial cell monolayers and migration toward fibronectin, type IV collagen, and laminin is partially mediated by CD44, a proteoglycan known to affect the functional abilities of tumor cells. The purpose of this study was to determine the role of cell membrane glycosylation in the metastatic abilities of ovarian carcinoma cells. NIH:OVCAR5 cells were treated with glycosidases to remove carbohydrate moieties from molecules on the cells' surface. The ability of the treated cells to adhere to extracellular matrix components or mesothelial cell monolayers, migrate toward extracellular matrix proteins, and invade through Matrigel was assessed. We observed that the loss of different carbohydrate moieties resulted in altered ovarian carcinoma cell adhesion, migration, and/or invasion toward extracellular matrix components or mesothelial cell monolayers. Gene array analysis of NIH:OVCAR5 cells revealed the expression of several proteoglycans, including syndecan 4, decorin, and perlecan. In tissue samples obtained from patients, altered proteoglycan gene expression was observed in primary ovarian carcinoma tumors and secondary metastases, compared to normal ovaries. Taken together, these results suggest that ovarian carcinoma cell proteoglycans affect the cells' ability to adhere, migrate, and invade toward extracellular matrix components and mesothelial cell monolayers. Thus, the carbohydrate modifications of several proteoglycans may mediate the formation and spread of secondary tumor growth in ovarian carcinoma.

Citing Articles

Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells.

Neuhaus F, Lieber S, Shinkevich V, Steitz A, Raifer H, Roth K Clin Transl Med. 2024; 14(4):e1604.

PMID: 38566518 PMC: 10988119. DOI: 10.1002/ctm2.1604.


KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer.

Shen K, Chen B, Yang L, Gao W Int J Genomics. 2023; 2023:4662480.

PMID: 37954130 PMC: 10635752. DOI: 10.1155/2023/4662480.


Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets.

Oto J, Le Q, Schafer S, Kiesel L, Mari-Alexandre J, Gilabert-Estelles J Cancers (Basel). 2023; 15(12).

PMID: 37370735 PMC: 10295974. DOI: 10.3390/cancers15123125.


Development of the Peritoneal Metastasis: A Review of Back-Grounds, Mechanisms, Treatments and Prospects.

Ren K, Xie X, Min T, Sun T, Wang H, Zhang Y J Clin Med. 2023; 12(1).

PMID: 36614904 PMC: 9821147. DOI: 10.3390/jcm12010103.


Syndecan-4 in Tumor Cell Motility.

Keller-Pinter A, Gyulai-Nagy S, Becsky D, Dux L, Rovo L Cancers (Basel). 2021; 13(13).

PMID: 34282767 PMC: 8268284. DOI: 10.3390/cancers13133322.


References
1.
Yeo T, Brown L, Dvorak H . Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol. 1991; 138(6):1437-50. PMC: 1886391. View

2.
LeBaron R, Zimmermann D, Ruoslahti E . Hyaluronate binding properties of versican. J Biol Chem. 1992; 267(14):10003-10. View

3.
Strobel T, Swanson L, Cannistra S . In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res. 1997; 57(7):1228-32. View

4.
Dhodapkar M, Abe E, Theus A, Lacy M, Langford J, Barlogie B . Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. Blood. 1998; 91(8):2679-88. View

5.
Ridley R, Xiao H, Hata H, Woodliff J, Epstein J, Sanderson R . Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood. 1993; 81(3):767-74. View